UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing disease geographic atrophy ...

A Corpus-Based Study on the Variations of Semantic Constraints over Mandarin Chinese VV Construction in Different Sentential Contexts ...